Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata

Journal of Clinical Investigation

Volumn 117, Issue 1, 2007, Pages 195-205

  Swirski, Filip K ^a,b,c   Libby, Peter ^b,c   Aikawa, Elena ^a   Alcaide, Pilar ^b   Luscinskas, F William ^b   Weissleder, Ralph ^a,c   Pittet, Mikael J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LY 6C ANTIGEN, MOUSE; LY ANTIGEN; LY-6C ANTIGEN, MOUSE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROMATOSIS; ATHEROSCLEROSIS; CELL ADHESION; CELL HETEROGENEITY; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FAT INTAKE; HYPERCHOLESTEROLEMIA; LIPID DIET; MACROPHAGE; MONOCYTE; MONOCYTOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; ANIMAL; BLOOD; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, LY; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HYPERCHOLESTEROLEMIA; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES;

EID: 33845970192     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI29950     Document Type: Article

References (55)

1. Hansson, G.K., and Libby, P. 2006. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 6:508-519.
2. Libby, P. 2002. Inflammation in atherosclerosis. Nature. 420:868-874.
3. Ridker, P.M., Hennekens, C.H., Buring, J.E., and Rifai, N. 2000. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342:836-843.
4. Peter, K., et al. 1997. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler. Thromb. Vasc. Biol. 17:505-512.
5. Barron, H.V., Cannon, C.P., Murphy, S.A., Braunwald, E., and Gibson, C.M. 2000. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation. 102:2329-2334.
6. Cannon, C.P., McCabe, C.H., Wilcox, R.G., Bentley, J.H., and Braunwald, E. 2001. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators. Am. J. Cardiol. 87:636-639; A610.
7. Friedman, G.D., Klatsky, A.L., and Siegelaub, A.B. 1974. The leukocyte count as a predictor of myocardial infarction. N. Engl. J. Med. 290:1275-1278.
8. Sabatine, M.S., et al. 2002. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction 18 trial) substudy. J. Am. Coll. Cardiol. 40:1761-1768.
9. Rothe, G., et al. 1996. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 16:1437-1447.
10. Imhof, B.A., and Aurrand-Lions, M. 2004. Adhesion mechanisms regulating the migration of monocytes. Nat. Rev. Immunol. 4:432-444.
11. van Furth, R., and Cohn, z.A. 1968. The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 128:415-435.
12. Volkman, A. 1970. The origin and fate of the monocyte. Ser. Haematol. 3:62-92.
13. Lessner, S.M., Prado, H.L., Waller, E.K., and Galis, z.S. 2002. Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. Am. J. Pathol. 160:2145-2155.
14. Rajavashisth, T., et al. 1998. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice. J. Clin. Invest. 101:2702-2710.
15. Kim, C.J., et al. 2000. Polymerase chain reaction-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tumor necrosis factor-alpha and interleukin-1 beta. Arterioscler. Thromb. Vasc. Biol. 20:1976-1982.
16. Swirski, F.K., et al. 2006. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc. Natl. Acad. Sci. U. S. A. 103:10340-10345.
17. Smith, J.D., et al. 1995. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. U. S. A. 92:8264-8268.
18. Ginhoux, F., et al. 2006. Langerhans cells arise from monocytes in vivo. Nat. Immunol. 7:265-273.
19. Gordon, S., and Taylor, P.R. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5:953-964.
20. Tacke, F., et al. 2006. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J. Exp. Med. 203:583-597.
21. Geissmann, F., Jung, S., and Littman, D.R. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 19:71-82.
22. Grage-Griebenow, E., Flad, H.D., and Ernst, M. 2001. Heterogeneity of human peripheral blood monocyte subsets. J. Leukoc. Biol. 69:11-20.
23. Passlick, B., Flieger, D., and ziegler-Heitbrock, H.W. 1989. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood. 74:2527-2534.
24. Sunderkotter, C., et al. 2004. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 172:4410-4417.
25. Plump, A.S., et al. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:343-353.
26. zhang, S.H., Reddick, R.L., Piedrahita, J.A., and Maeda, N. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:468-471.
27. Clinton, S.K., et al. 1992. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am. J. Pathol. 140:301-316.
28. Chen, Y.C., et al. 2005. Apolipoprotein E is required for cell proliferation and survival in ovarian cancer. Cancer Res. 65:331-337.
29. Grainger, D.J., Reckless, J., and McKilligin, E. 2004. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice. J. Immunol. 173:6366-6375.
30. Galkina, E., et al. 2006. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J. Exp. Med. 203:1273-1282.
31. Nelken, N.A., Coughlin, S.R., Gordon, D., and Wilcox, J.N. 1991. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest. 88:1121-1127.
32. Yla-Herttuala, S., et al. 1991. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. U. S. A. 88:5252-5256.
33. Guo, J., et al. 2003. Transplantation of monocyte CC-chemokine receptor 2-deficient bone marrow into ApoE3-Leiden mice inhibits atherogenesis. Arterioscler. Thromb. Vasc. Biol. 23:447-453.
34. Veillard, N.R., et al. 2005. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo. Circulation. 112:870-878.
35. Gu, L., et al. 1998. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell. 2:275-281.
36. Baigent, C., et al. 2005. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 366:1267-1278.
37. Ridker, P.M., et al. 2005. C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med. 352:20-28.
38. O'Keeffe, M., et al. 2003. Dendritic cell precursor populations of mouse blood: identification of the murine homologues of human blood plasmacytoid pre-DC2 and CD11c+ DC1 precursors. Blood. 101:1453-1459.
39. Witztum, J.L., and Steinberg, D. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1785-1792.
40. Parhami, F., et al. 1993. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J. Clin. Invest. 92:471-478.
41. Shi, W., Haberland, M.E., Jien, M.L., Shih, D.M., and Lusis, A.J. 2000. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation. 102:75-81.
42. Hamilton, J.A., et al. 1999. Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler. Thromb. Vasc. Biol. 19:98-105.
43. Hundal, R.S., et al. 2001. Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathway. J. Lipid Res. 42:1483-1491.
44. Hanninen, A., Jaakkola, I., Salmi, M., Simell, O., and Jalkanen, S. 1997. Ly-6C regulates endothelial adhesion and homing of CD8(+) T cells by activating integrin-dependent adhesion pathways. Proc. Natl. Acad. Sci. U. S. A. 94:6898-6903. 45. Jutila, M.A., et al. 1988. Ly-6C is a monocyte/macrophage and endothelial cell differentiation antigen regulated by interferon-gamma. Eur. J. Immunol. 18:1819-1826.
45. Pflugh, D.L., Maher, S.E., and Bothwell, A.L. 2002. Ly-6 superfamily members Ly-6A/E, Ly-6C, and Ly-6I recognize two potential ligands expressed by B lymphocytes. J. Immunol. 169:5130-5136.
46. Poston, R.N., and Hussain, I.F. 1993. The immunohistochemical heterogeneity of atheroma macrophages: comparison with lymphoid tissues suggests that recently blood-derived macrophages can be distinguished from longer-resident cells. J. Histochem. Cytochem. 41:1503-1512.
47. van der Wal, A.C., Becker, A.E., van der Loos, C.M., and Das, P.K. 1994. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 89:36-44.
48. Mantovani, A., Sica, A., and Locati, M. 2005. Macrophage polarization comes of age. Immunity. 23:344-346.
49. Mantovani, A., et al. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25:677-686.
50. Afiune Neto, A., Mansur Ade, P., Avakian, S.D., Gomes, E.P., and Ramires, J.A. 2006. Monocytosis is an independent risk marker for coronary artery disease [In Portuguese]. Arq. Bras. Cardiol. 86:240-244.
51. Kleemann, R., et al. 2004. Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro. Blood. 103:4188-4194.
52. Van Rooijen, N., and Sanders, A. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods. 174:83-93.
53. Lim, Y.C., et al. 2003. Heterogeneity of endothelial cells from different organ sites in T-cell subset recruitment. Am. J. Pathol. 162:1591-1601.
54. Luscinskas, F.W., et al. 1994. Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins. J. Cell Biol. 125:1417-1427.
55. Aikawa, E., et al. 2006. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation. 113:1344-1352.